The 4th ArtCAN is a unique and original fund raising event that features a fine art auction and original performances from selected acclaimed performing and visual artists from around the world who have been closely affected by cancer. In an unprecedented collaboration, ArtCAN is proud to announce it has brought together partnerships with the Atlanta Ballet, The Atlanta Opera, The Atlanta Symphony Orchestra to help raise money & awareness for Pancreatic Cancer. ArtCAN benefits the Joseph C. Monastra (JCM) Foundation for Pancreatic Cancer Research, which supports pancreatic cancer research at Johns Hopkins and Emory University.
Back for its fourth year ArtCAN, takes place on Saturday, November 19, 2016 and is hosted at The Estate By Legendary Events. Two highly acclaimed curatorial panels comprised of esteemed performing and visual art professionals have been assembled to review and select those artists to be featured at this year’s event.
Members of the Visual Arts Curatorial Panel: Alan Avery, owner Alan Avery Art Company; Jerry Cullum, renowned art critic; Hope Cohn, art consultant and curator; and Timothy Tew, owner TEW Fine Art Gallery.
Members of the Performing Arts Curatorial Panel: Armando Luna, principal teacher at the Atlanta Ballet; Juan Ramirez, violinist, composer and conductor with the Atlanta Symphony Orchestra; and a representative from the Atlanta Opera to be announced soon.
ArtCAN blends together two very different worlds – the beauty and intrigue of the Art world with the tenuous emotions Cancer brings into our world. ArtCAN features performing and visual artists who have been affected closely by cancer – any cancer not just pancreatic cancer. We developed the principal idea that art CAN heal, art CAN empower, and art CAN impact a great number of people. ArtCAN brings together an entire global community of cancer survivors and those affected by cancer, standing together to fight the deadliest of all cancers – Pancreatic Cancer.
Pancreatic Cancer is one of the deadliest cancers and is the 3rd leading cause of cancer deaths in the U.S. for both men and women. With an increasing mortality rate, no warning signs and no early detection pancreatic cancer will continue to be the “silent killer,” brutally and quickly taking the lives of loved ones. It is estimated that this year nearly 53,070 Americans will be diagnosed with cancer of the pancreas. Only 7.7% of Pancreatic Cancer patients will survive beyond 5 years.
There is gaining global awareness regarding Pancreatic Cancer and its terrifying circumstances. For those of us closely affected by Pancreatic Cancer we understand that finding an early detection is paramount to survival, and the greater population is beginning to understand this notion. It is the early detection methods that have saved so many breast and prostate cancer survivors. It’s an early detection that will allow there to be a fair fight against Pancreatic Cancer, bringing hope for the first time to those diagnosed.
In 2002, Joseph C. Monastra was diagnosed with Pancreatic Cancer, and in just four short weeks the disease took his life. Devastated by the loss, the wife and daughters of Joseph founded the Joseph C. Monastra Foundation and started raising money for pancreatic cancer research. The JCM Foundation has been supporting the research of Dr. Christine Iacobuzio-Donahue, Professor Oncology & Pathology at Johns Hopkins, for the past 11 years. In 2013, the JCM Foundation extended its research support to Emory University and the research led by Dr. Volkan Adsay, Vice Chair of Oncology and Pathology.
Please help us raise money and awareness for critical Pancreatic Cancer research by supporting ArtCAN in one of many ways: